Loading stock data...

Cipla Limited

NSE: CIPLA BSE: CIPLA

NSE
1,511.60 10.70 (0.71%)

Prev Close

1500.9

Open Price

1500.9

Volume

963,809

Today Low / High

1498.6 / 1517.8

52 WK Low / High

1335 / 1673

Range

1,436 - 1,587

BSE
1,510.95 10.85 (0.72%)

Prev Close

1500.1

Open Price

1509.55

Volume

35,406

Today Low / High

1499 / 1518

52 WK Low / High

1310.05 / 1672.2

Range

1,435 - 1,586

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1511.6 (target range: 1,436 - 1,587), reflecting a change of 10.7 (0.71291%). On the BSE, it is listed at 1510.95 (target range: 1,435 - 1,586), showing a change of 10.85 (0.72329%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

02 Jan 1,500.90 0.71%
01 Jan 1,512.00 -0.73%
31 Dec 1,492.50 1.26%
30 Dec 1,494.00 -0.10%
29 Dec 1,506.00 -0.80%
26 Dec 1,496.30 0.65%
24 Dec 1,502.50 -0.41%
23 Dec 1,520.40 -1.30%
22 Dec 1,513.00 -0.01%
19 Dec 1,495.50 1.44%
18 Dec 1,494.80 0.27%
17 Dec 1,497.60 -0.05%
16 Dec 1,500.00 -0.03%
15 Dec 1,505.00 0.20%
12 Dec 1,520.00 -0.17%
11 Dec 1,492.00 1.36%
10 Dec 1,492.00 -0.07%
09 Dec 1,497.60 -0.47%
08 Dec 1,515.10 -1.16%

Cipla Limited Graph

Cipla Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Cipla Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,511.60, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 1,510.95 1,526.06 1,373.45 - 1,678.67
1,541.17 1,232.94 - 1,849.40
1,556.28 1,089.39 - 2,023.16
Bearish Scenario 1,510.95 1,495.84 1,346.26 - 1,645.42
1,480.73 1,184.58 - 1,776.88
1,465.62 1,025.94 - 1,905.31

Overview of Cipla Limited

ISIN

INE059A01026

Industry

Drug Manufacturers - General

Vol.Avg

1,250,578

Market Cap

1,221,017,765,973

Last Dividend

13

Official Website

Visit Website

IPO Date

1996-01-01

DCF Diff

-1,573.50

DCF

3,116

Financial Ratios Every Investor Needs

Stock Dividend of CIPLA

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-06-27 June 27, 25 16 16 2025-06-27 2025-08-15
2024-08-02 August 02, 24 13 13 2024-08-02 2024-09-19
2023-07-21 July 21, 23 8.5 8.5 2023-07-21 2023-09-09
2022-08-08 August 08, 22 5 5 2022-08-10 2022-09-25
2021-08-09 August 09, 21 5 5 2021-08-10 2021-09-24

Stock Rating Details for CIPLA

Metric Value Recommendation
Overall Rating A Buy
DCF Score 5 Strong Buy
ROE Score 4 Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 4 Buy
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 27,267.44 Cr 9,175.30 Cr 18,092.14 Cr 0.6635 1,484.83 Cr 4,944.67 Cr 10,500.58 Cr 5,272.52 Cr 65.29 7,022.14 Cr 0.1934
2024-03-31 25,536.71 Cr 9,043.95 Cr 16,492.76 Cr 0.6458 1,523.08 Cr 4,402.69 Cr 9,479.58 Cr 4,121.55 Cr 51.05 6,190.67 Cr 0.1614
2023-03-31 22,559.25 Cr 8,455.17 Cr 14,104.08 Cr 0.6252 1,293.02 Cr 3,916.94 Cr 7,795.94 Cr 2,801.91 Cr 34.72 4,918.98 Cr 0.1242
2022-03-31 21,707.84 Cr 8,690.21 Cr 13,017.63 Cr 0.5997 265.68 Cr 3,608.09 Cr 8,085.03 Cr 2,516.75 Cr 31.20 4,439.30 Cr 0.1159
2021-03-31 19,120.53 Cr 7,506.37 Cr 11,614.16 Cr 0.6074 133.07 Cr 3,327.69 Cr 7,352.97 Cr 2,404.87 Cr 29.82 4,124.30 Cr 0.1258

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 588.69 Cr 37,387.04 Cr 6,097.79 Cr 31,193.4500 Cr 439.43 Cr -149.26 Cr 5,642.11 Cr 6,586.27 Cr 0.00 Cr 56.75 Cr 811.07 Cr 5,483.9600 Cr
2024-03-31 640.07 Cr 32,717.82 Cr 5,915.29 Cr 26,706.6300 Cr 560.30 Cr -79.77 Cr 5,237.95 Cr 6,046.90 Cr 0.00 Cr 61.94 Cr 1,053.06 Cr 5,245.7700 Cr
2023-03-31 627.63 Cr 29,463.28 Cr 5,749.74 Cr 23,407.7800 Cr 803.12 Cr 175.49 Cr 5,156.43 Cr 5,739.78 Cr 0.00 Cr 52.11 Cr 573.54 Cr 5,109.6700 Cr
2022-03-31 677.74 Cr 27,101.12 Cr 5,983.74 Cr 20,841.6900 Cr 1,055.78 Cr 378.04 Cr 5,350.24 Cr 5,608.72 Cr 0.00 Cr 51.46 Cr 678.78 Cr 4,913.2100 Cr
2021-03-31 793.29 Cr 25,151.89 Cr 6,566.30 Cr 18,326.5300 Cr 2,024.11 Cr 1,230.82 Cr 4,669.18 Cr 5,648.86 Cr 0.00 Cr 63.61 Cr 423.68 Cr 4,591.5500 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 5,004.9800 Cr -3,691.1400 Cr -1,292.7900 Cr 3,842.8200 Cr 30.3100 Cr 542.6500 Cr -1,162.1600 Cr 5,272.5200 Cr -86.0500 Cr -1,049.8300 Cr -322.5400 Cr
2024-03-31 4,133.9100 Cr -2,988.0300 Cr -1,200.4300 Cr 2,784.6100 Cr -48.9900 Cr 512.3400 Cr -1,098.2500 Cr 4,121.5500 Cr -300.4600 Cr -686.1700 Cr -61.8600 Cr
2023-03-31 3,237.6500 Cr -2,388.5100 Cr -958.2900 Cr 2,054.7600 Cr -96.7800 Cr 561.3300 Cr -840.5300 Cr 4,220.7700 Cr -351.9000 Cr -403.5000 Cr 110.7700 Cr
2022-03-31 3,325.9000 Cr -1,871.8800 Cr -1,599.7900 Cr 2,624.7500 Cr -132.3200 Cr 658.1100 Cr -701.1500 Cr 3,675.3900 Cr -1,006.2300 Cr -403.3500 Cr -621.1100 Cr
2021-03-31 3,755.2000 Cr -2,387.1800 Cr -1,239.5100 Cr 2,936.2800 Cr 50.5800 Cr 793.2900 Cr -629.6600 Cr 3,290.0600 Cr -993.1300 Cr 0.0000 Cr -254.3200 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 7,589.44 Cr 4,109.43 Cr 3,480.01 Cr 0.4585 1,597.76 Cr 1,351.17 Cr 16.73 2,163.70 Cr 0.1780
2025-06-30 6,957.47 Cr 3,735.73 Cr 3,221.74 Cr 0.4631 1,525.42 Cr 1,297.62 Cr 16.07 2,036.70 Cr 0.1865
2025-03-31 6,719.76 Cr 2,435.33 Cr 4,284.43 Cr 0.6376 292.60 Cr 1,221.84 Cr 15.13 1,560.29 Cr 0.1818
2024-12-31 6,961.60 Cr 2,264.08 Cr 4,697.52 Cr 0.6748 3,499.90 Cr 1,570.51 Cr 19.45 1,919.43 Cr 0.2256
2024-09-30 6,961.22 Cr 2,283.01 Cr 4,678.21 Cr 0.6720 3,470.33 Cr 1,302.53 Cr 16.13 1,873.06 Cr 0.1871

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 795.85 Cr 7,539.48 Cr 8,335.33 Cr 6,920.28 Cr 6,160.12 Cr 24,918.02 Cr 6,939.58 Cr 40,164.22 Cr 7,139.39 Cr
2025-06-30 0.00 Cr 0.00 Cr 10,617.20 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -31,289.25 Cr
2025-03-31 588.69 Cr 10,020.59 Cr 10,617.20 Cr 5,506.37 Cr 5,642.11 Cr 23,288.52 Cr 6,586.27 Cr 37,387.04 Cr 6,097.79 Cr
2024-12-31 0.00 Cr 0.00 Cr 8,708.20 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -28,455.78 Cr
2024-09-30 921.44 Cr 7,786.76 Cr 8,708.20 Cr 5,587.56 Cr 5,572.86 Cr 20,945.21 Cr 6,328.95 Cr 34,655.28 Cr 6,199.50 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 1,297.62 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 1,221.84 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 1,570.51 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 1,302.53 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1,177.64 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2006-04-24 April 24, 06 5:2
2004-05-11 May 11, 04 5:1
1999-10-21 October 21, 99 3:1
1999-10-18 October 18, 99 3:1

Similar Stocks: Drug Manufacturers - General

Company Name Symbol Price Market Cap Volume
Cipla Limited CIPLA ₹1,511.60 ₹1,221,017,765,973.00 ₹963,809.00
Abbott India Limited ABBOTINDIA ₹28,125.00 ₹597,636,618,750.00 ₹10,290.00
GlaxoSmithKline Pharmaceuticals Limited GLAXO ₹2,483.80 ₹420,770,707,249.00 ₹27,467.00
Gland Pharma Limited GLAND ₹1,715.80 ₹282,689,070,583.00 ₹55,895.00
Pfizer Limited PFIZER ₹4,887.20 ₹223,578,315,830.00 ₹15,604.00
Sanofi Consumer Healthcare India Ltd. SANOFICONR ₹4,595.80 ₹105,844,132,588.00 ₹1,491.00
Sanofi India Limited SANOFI ₹4,141.80 ₹95,388,230,200.00 ₹7,554.00
Marksans Pharma Limited MARKSANS ₹182.19 ₹82,561,902,884.00 ₹513,179.00
Senores Pharmaceuticals Ltd. SENORES ₹865.30 ₹39,850,169,696.00 ₹583,319.00
SMS Pharmaceuticals Limited SMSPHARMA ₹326.25 ₹29,077,526,171.00 ₹429,592.00

Key Executives

President & Global Chief People Officer
Raju Sunil Mistry

Gender: Not Specified

Year Born: 1965

Global Chief Operating Officer
Achin Gupta

Gender: male

Year Born: 1976

Global Chief Financial Officer
Ashish Adukia

Gender: male

Year Born:

Senior Vice President & Head of Corporate Finance
Dinesh Ramniranjan Jain

Gender: male

Year Born:

President & Global Chief Scientific Officer
Pradeep Bhadauria

Gender: male

Year Born:

Compliance Officer & Company Secretary
Rajendra Kumar Chopra

Gender: male

Year Born:

MD, Global Chief Executive Officer & Executive Director
Umang Vohra

Gender: male

Year Born: 1971

Head of Investor Relations
Diksha Maheshwari

Gender: female

Year Born:

Chief Information Officer
Sneha Hiranandani

Gender: female

Year Born:

Global General Counsel
A. S. Kumar

Gender: Not Specified

Year Born:

FAQs about Cipla Limited

Who is the CEO of the company?

The CEO is Umang Vohra.

What is the current market price of the stock?

The current price is ₹1,511.60.

What is the 52-week price range?

The range is ₹1335-1673.

What is the market capitalization of the company?

The market capitalization is ₹122,101.78 crores.

What is the dividend yield?

The dividend yield is 1.06%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 22.44.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Cipla Limited (ISIN: INE059A01026) is a leading Drug Manufacturers - General in India. With a market capitalization of ₹122,101.78 crores and an average daily volume of 1,250,578 shares, it operates in the Drug Manufacturers - General. The company last declared a dividend of ₹13.